Skip to content
Guavy Logo GUAVY
Sign up
Back to Guavy Wire
Stocks

Merck Sued by Biotech NPE in Patent Dispute over LOT Network/Canon Patents

Guavy AI Editorial Team
Instruments
MRK
Share

Merck has been sued by biotech NPE (Non-Practicing Entity) in a patent dispute related to former LOT Network/Canon patents. This is not an isolated incident, as Ericsson recently sold 332 patent assets in 89 families to a patent licensing firm.

The lawsuit highlights the growing trend of patent disputes between companies and NPEs. Acer's IP head has been pushing to unlock portfolio value while navigating SEP (Standard-Essential Patent) battles.

More on Stocks

Stocks just now

Apple Expands Tap to Pay on iPhone to Eight More Latin American Countries

Stocks just now

Tay Keith Estate Hit with $200k in Claims, Including Luxury Car Loan

Stocks 2m ago

McDonald's Tries Ads on Menu Screens as Part of Revamp Efforts

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Guavy Logo GUAVY

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

© 2026 Guavy Inc

Terms Privacy Policy